A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...
Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular, inflammatory, and fibrotic diseases, is presenting new translational data on its oral ...
Eli Lilly and Co. LLY shares are trading higher on Tuesday as the company is reporting new data on its treatment for ...
Data highlight both SER-603’s rational design that targets microbial functions linked to mucosal healing and gastrointestinal inflammation in ...
Water is often dubbed the elixir of life, and for a good reason. It is a crucial component of our bodies, making up about 60 percent of our total body weight. Every cell, tissue and organ in our body ...
Dear Doctors: I’m a 77-year-old man and was having trouble with hard stools. My doctor suggested a stool softener. It worked for about a week, but then I developed diarrhea. Over-the-counter diarrhea ...
"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...
A stem cell-derived intestine model reveals glycyrrhizin as a potential treatment for inflammatory bowel disease.
Treatment for short bowel syndrome varies by stage and may include intravenous (IV) nutrition, feeding tubes, dietary changes ...
Celltrion, Inc. today announced that seven abstracts will be presented at the 2026 Digestive Disease Week® (DDW) Annual Meeting, taking place May 2-5 in Chicago, Illinois. The oral and poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results